Please use this identifier to cite or link to this item: http://repository.futminna.edu.ng:8080/jspui/handle/123456789/11987
Full metadata record
DC FieldValueLanguage
dc.contributor.authorZakari, Hashimu-
dc.contributor.authorKatnap, R.S.-
dc.contributor.authorAjang, A.Y-
dc.contributor.authorOgbe, A.-
dc.contributor.authorAnejo-Okopi, J.A.-
dc.contributor.authorAdabara, Nasiru Usman-
dc.date.accessioned2021-07-28T16:03:50Z-
dc.date.available2021-07-28T16:03:50Z-
dc.date.issued2016-11-30-
dc.identifier.urihttp://repository.futminna.edu.ng:8080/jspui/handle/123456789/11987-
dc.description.abstractAbstract Urinary tract infection is one of the infections observed among HIV patients and the cause of morbidity and hospitalisation in HIV positive individuals. The study aimed at determining the prevalence of Urinary tract pathogenic bacteria and yeast among HIV-infected individuals attending Anti-retroviral therapy (ART) clinic in Jos,Nigeria. Mid-stream urine samples collected from 240 HIV seropositive patients were cultured, isolates identified and antibiotic susceptibility profile determined using agar disk diffusion technique (Kirby-Baeur). Out of the 240 samples screened, 39(16.25%) had urinary tract infections (UTIs) and 33(16.20%) had yeast infection. The distribution of the isolates were as follows: Escherichia coli 12(30.77%), Staphylococcus aureus 10(25.64%), Klebsiella pneumonia 4(10.26%), Enterobacter sp. 4(10.26%), Staphylococcus saprophyticus 3(7.69%), Citrobacter freundii 2(5.13%), Pseudomonas aeruginosa 2(5.13%) and Proteus mirabilis 1(2.567%).Among the yeasts, Candida albicans showed the highest prevalence with 21(63.64%) while non-albican Candida sp had 12(36.36%). Age group 20-24 years with 1(33.3%) cases had the highest prevalence while bacterial infection was not detected among <19, 55-59 and ≥60 years. Females had a higher prevalence of 36(17.60%) compared to the males 3(8.33%).The antibiotic susceptibility patterns showed that gentamicin (10µg), augmentin (20µg), chloramphenicol (30µg), ciprofloxacin (5µg) and ofloxacin (5µg) were more active. The study revealed that uropathogenic bacteria and yeast were prevalent among HIV/AIDS patients. Routine screening of uropathogens should be incorporated in the management and care of HIV/AIDS patients in Nigeria.en_US
dc.language.isoenen_US
dc.publisherUMYU Journal of Microbiology Researchen_US
dc.subjectUropathogenic bacteria, Yeast cells, HIV/AIDS, Antibiotic susceptibility testen_US
dc.titleOccurrence of Bacteria and Yeast in Urinary Tract of HIV/AIDS Patients Attending Antiretroviral Therapy (ART) Clinic at University of Jos Teaching Hospital, Nigeriaen_US
dc.typeArticleen_US
Appears in Collections:Microbiology

Files in This Item:
File Description SizeFormat 
UJMR 1_1 2016_012.pdf127.61 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.